Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparing de novo chronic myeloid leukemia in blastic phase with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.
Okada Y, Tachi N, Shimazu Y, Murata M, Nishiwaki S, Onishi Y, Jinguji A, Uchida N, Tanaka M, Hasegawa Y, Ito A, Kako S, Nishida T, Onodera K, Sawa M, Nakamae H, Toyosaki M, Kanda Y, Onizuka M, Fukuda T, Ohbiki M, Atsuta Y, Arai Y, Tachibana T. Okada Y, et al. Among authors: arai y. Cancer. 2025 Jan 1;131(1):e35627. doi: 10.1002/cncr.35627. Epub 2024 Nov 4. Cancer. 2025. PMID: 39497254
Poor outcome of allogeneic transplantation for therapy-related acute myeloid leukemia induced by prior chemoradiotherapy.
Araie H, Arai Y, Kida M, Aoki J, Uchida N, Doki N, Fukuda T, Tanaka M, Ozawa Y, Sawa M, Katayama Y, Matsuo Y, Onizuka M, Kanda Y, Kawakita T, Kanda J, Atsuta Y, Yanada M; Adult Acute Myeloid Leukemia Working Group of the Japanese Society for Transplantation and Cellular Therapy. Araie H, et al. Among authors: arai y. Ann Hematol. 2023 Oct;102(10):2879-2893. doi: 10.1007/s00277-023-05356-6. Epub 2023 Jul 21. Ann Hematol. 2023. PMID: 37477669 Free PMC article.
Reduced-intensity allogenic transplantation for children and adolescents with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Ishida H, Arakawa Y, Hasegawa D, Usami I, Hashii Y, Arai Y, Nishiwaki S, Keino D, Kato K, Sato M, Yoshida N, Ozawa Y, Okada K, Hidaka M, Yuza Y, Tanaka M, Watanabe K, Takita J, Kosaka Y, Fujita N, Tanaka J, Sato A, Atsuta Y, Imamura T. Ishida H, et al. Among authors: arai y. Ann Hematol. 2024 Mar;103(3):843-854. doi: 10.1007/s00277-023-05557-z. Epub 2023 Nov 25. Ann Hematol. 2024. PMID: 38006571
Prognostic factors in haploidentical transplantation with post-transplant cyclophosphamide for acute myeloid leukemia.
Shibata S, Arai Y, Kondo T, Mizuno S, Yamasaki S, Akasaka T, Doki N, Ota S, Maruyama Y, Matsuoka KI, Nagafuji K, Eto T, Tanaka T, Ohigashi H, Nakamae H, Onizuka M, Fukuda T, Atsuta Y, Yanada M. Shibata S, et al. Among authors: arai y. Cytotherapy. 2024 Jun;26(6):592-598. doi: 10.1016/j.jcyt.2024.02.010. Epub 2024 Feb 23. Cytotherapy. 2024. PMID: 38466265 Free article.
Center effect on allogeneic hematopoietic stem cell transplantation outcomes for B-cell acute lymphoblastic leukemia.
Kurosawa S, Fukuda T, Ichinohe T, Hashii Y, Kanda J, Goto H, Kato K, Yoshimitsu M, Ishimaru F, Sato A, Onizuka M, Matsuo K, Ito Y, Yanagisawa A, Ohbiki M, Tabuch K, Atsuta Y, Arai Y; Japanese Society for Transplantation and Cellular Therapy (JSTCT). Kurosawa S, et al. Among authors: arai y. Cytotherapy. 2024 Oct;26(10):1185-1192. doi: 10.1016/j.jcyt.2024.05.004. Epub 2024 May 9. Cytotherapy. 2024. PMID: 38804991
Advantages of Higher Busulfan Dose Intensity in Fludarabine-Combined Conditioning for Patients with Acute Myeloid Leukemia Undergoing Cord Blood Transplantation.
Shibata S, Arai Y, Kondo T, Mizuno S, Harada K, Miyakoshi S, Uchida N, Maruyama Y, Eto T, Katsuoka Y, Matsue K, Nishiwaki K, Takada S, Doki N, Itoh M, Nagafuji K, Kawakita T, Tanaka J, Fukuda T, Atsuta Y, Yanada M. Shibata S, et al. Among authors: arai y. Transplant Cell Ther. 2023 May;29(5):332.e1-332.e11. doi: 10.1016/j.jtct.2023.02.004. Epub 2023 Feb 14. Transplant Cell Ther. 2023. PMID: 36796517 Free article.
[Manufacturing results of tisagenlecleucel for acute lymphoblastic leukemia: a survey by the CAR-T cell therapy taskforce of the Japan Society of Transfusion Medicine and Cell Therapy].
Jo T, Henzan T, Tomizawa D, Yoshihara S, Kahata K, Yamada-Fujiwara M, Okuyama Y, Shiba N, Fujii K, Umezawa Y, Yamazaki R, Takeda W, Hanajiri R, Fukushima K, Mimura N, Ikemoto J, Iwaki K, Yonetani N, Fujiwara SI, Ri M, Nagamura-Inoue T, Tanosaki R, Arai Y. Jo T, et al. Among authors: arai y. Rinsho Ketsueki. 2023;64(5):331-337. doi: 10.11406/rinketsu.64.331. Rinsho Ketsueki. 2023. PMID: 37271521 Japanese.
4,199 results